Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

NCT00196586 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infections
Chronic Hepatitis C

Interventions

DRUG: Interleukin 2
DRUG: pegylated interferon alpha 2a
DRUG: ribavirin

Sponsor

French National Agency for Research on AIDS and Viral Hepatitis

Collaborators

[object Object]